AIXN supply chain intelligence for AiXin Life International, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
AiXin Life International, Inc. (AIXN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| AIXINTANG-XINFU-PHARMACY-CHAIN-CO-LTD | AIXINTANG-XINFU-PHARMACY-CHAIN-CO-LTD | 90% | Chengdu Aixin International Travel Service Co., Ltd. 4,676 3,258 |
| CHENGDU-LISHENG-HUIRENTANG-PHARMACY-CO-LTD | CHENGDU-LISHENG-HUIRENTANG-PHARMACY-CO-LTD | 90% | Chengdu Lisheng Huirentang Pharmacy Co., Ltd 785 60,223 |
| SHENGCAOFENG-HEALTH-INDUSTRY-YUNNAN-CO-LTD | SHENGCAOFENG-HEALTH-INDUSTRY-YUNNAN-CO-LTD | 90% | Shengcaofeng Health Industry (Yunnan) Co., Ltd. 656,621 - |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CHENGDU-CIGU-FOSHOU-PHARMACY-CO-LTD | CHENGDU-CIGU-FOSHOU-PHARMACY-CO-LTD | 90% | Chengdu Cigu Foshou Pharmacy Co., Ltd. 1,444 - |
| CHENGDU-HESHENGYUAN-PHARMACY-CO-LTD | CHENGDU-HESHENGYUAN-PHARMACY-CO-LTD | 90% | Chengdu Heshengyuan Pharmacy Co., Ltd. 2,426 1,529 |
| SHENGCAOFENG-HEALTH-INDUSTRY-YUNNAN-CO-LTD | SHENGCAOFENG-HEALTH-INDUSTRY-YUNNAN-CO-LTD | 90% | Shengcaofeng Health Industry (Yunnan) Co., Ltd. - 1,206 |
| SICHUAN-AIXINTANG-XINFU-PHARMACY-CHAIN-CO-LTD | SICHUAN-AIXINTANG-XINFU-PHARMACY-CHAIN-CO-LTD | 90% | Sichuan Aixintang Xinfu Pharmacy Chain Co., Ltd. $ 57,136 $ 75,474 |
| SICHUAN-YUNXITANG-PHARMACY-CO-LTD | SICHUAN-YUNXITANG-PHARMACY-CO-LTD | 90% | Sichuan Yunxitang Pharmacy Co., Ltd. 111 370 |
| AIXINTANG-TANG-HAI-CHUAN-HAI-CHUAN-DA-PHARMACY-C | AIXINTANG-TANG-HAI-CHUAN-HAI-CHUAN-DA-PHARMACY-C | 62% | ommenced February 29, 2024 and expires April 15, 2034. The lease grants us the right to occupy various areas within the hotel, covering approximately 18,000 square meters, including the first-floor l… |
| BVI-INTERNATIONAL-GROUP-LTD | BVI-INTERNATIONAL-GROUP-LTD | 62% | s are wholly owned through an intermediary company established in Hong Kong named HK AiXin International Group Co., Limited (“AiXin HK” and collectively with our Chinese Operating Companies our “PRC … |
| CHENGDU-AIXIN-E-COMMERCE-CO-LTD | CHENGDU-AIXIN-E-COMMERCE-CO-LTD | 62% | disruptions may also have the effect of heightening many of the other risks described in this section. If these disruptions or other matters of global concern continue for an extensive period of time… |
| CHENGDU-AIXIN-SHANGYAN-HOTEL-MANAGEMENT-CO-LTD | CHENGDU-AIXIN-SHANGYAN-HOTEL-MANAGEMENT-CO-LTD | 62% | ommenced February 29, 2024 and expires April 15, 2034. The lease grants us the right to occupy various areas within the hotel, covering approximately 18,000 square meters, including the first-floor l… |
| CHENGDU-AIXIN-ZHONGHONG-BIOLOGICAL-TECHNOLOGY-CO | CHENGDU-AIXIN-ZHONGHONG-BIOLOGICAL-TECHNOLOGY-CO | 62% | earch and development of new products intended to improve individuals’ health and well-being, with an emphasis on functional products comprised of natural plants, foods and supplements intended to ad… |
| CHENGDU-AIXINZHONGHONG-BIOLOGICAL-TECHNOLOGY-CO- | CHENGDU-AIXINZHONGHONG-BIOLOGICAL-TECHNOLOGY-CO- | 62% | ommenced February 29, 2024 and expires April 15, 2034. The lease grants us the right to occupy various areas within the hotel, covering approximately 18,000 square meters, including the first-floor l… |
| CHINA-CONCENTRIC-CAPITAL-GROUP | CHINA-CONCENTRIC-CAPITAL-GROUP | 62% | anslation loss - - - - - ( 243,885 ) ( 243,885 ) Balance at December 31, 2025 24,999,834 250 15,276,550 151,988 ( 22,031,196 ) 33,657 ( 6,568,751 ) The accompanying notes are an integral part of thes… |
| CHINA-TRADING-CO-LTD | CHINA-TRADING-CO-LTD | 62% | earch and development of new products intended to improve individuals’ health and well-being, with an emphasis on functional products comprised of natural plants, foods and supplements intended to ad… |
| CO-LTD | CO-LTD | 62% | armacy Co., Ltd (which together with certain affiliated entities is referred to as “Chengdu Aixintang Pharmacies”), and Yunnan Runcangsheng Technology Co., Ltd. (“Runcangsheng).” The Chinese Operatin… |
| HK-AIXIN-INTERNATIONAL-GROUP-CO-LIMITED | HK-AIXIN-INTERNATIONAL-GROUP-CO-LIMITED | 62% | s are wholly owned through an intermediary company established in Hong Kong named HK AiXin International Group Co., Limited (“AiXin HK” and collectively with our Chinese Operating Companies our “PRC … |
| JIUJIANG-GONGQINGCHENG-DISHI-INVESTMENT-MANAGEME | JIUJIANG-GONGQINGCHENG-DISHI-INVESTMENT-MANAGEME | 62% | earch and development of new products intended to improve individuals’ health and well-being, with an emphasis on functional products comprised of natural plants, foods and supplements intended to ad… |
| LIQUIDITY-CAPITAL-RESOURCES | LIQUIDITY-CAPITAL-RESOURCES | 62% | on and products they need cost effectively. Our revenue will largely be determined by our ability to achieve and maintain a strong brand name and company image, the volume of products we sell and the… |
| SICHUAN-AIXIN-INVESTMENT-CO-LTD | SICHUAN-AIXIN-INVESTMENT-CO-LTD | 62% | disruptions may also have the effect of heightening many of the other risks described in this section. If these disruptions or other matters of global concern continue for an extensive period of time… |
| SICHUAN-CREATIVITY-INFORMATION-TECHNOLOGY-CO-LTD | SICHUAN-CREATIVITY-INFORMATION-TECHNOLOGY-CO-LTD | 62% | earch and development of new products intended to improve individuals’ health and well-being, with an emphasis on functional products comprised of natural plants, foods and supplements intended to ad… |
| SICHUAN-HUIANRONG-INFORMATION-TECHNOLOGY-CO-LTD | SICHUAN-HUIANRONG-INFORMATION-TECHNOLOGY-CO-LTD | 62% | earch and development of new products intended to improve individuals’ health and well-being, with an emphasis on functional products comprised of natural plants, foods and supplements intended to ad… |
| SICHUAN-JINGUANG-CHEMICALS-CO-LTD | SICHUAN-JINGUANG-CHEMICALS-CO-LTD | 62% | earch and development of new products intended to improve individuals’ health and well-being, with an emphasis on functional products comprised of natural plants, foods and supplements intended to ad… |
| SICHUAN-MINGHOUTIAN-INFORMATION-TECHNOLOGY-CO-LT | SICHUAN-MINGHOUTIAN-INFORMATION-TECHNOLOGY-CO-LT | 62% | earch and development of new products intended to improve individuals’ health and well-being, with an emphasis on functional products comprised of natural plants, foods and supplements intended to ad… |
| YUNNAN-RUNCANGSHENG-TECHNOLOGY-CO-LTD | YUNNAN-RUNCANGSHENG-TECHNOLOGY-CO-LTD | 62% | armacy Co., Ltd (which together with certain affiliated entities is referred to as “Chengdu Aixintang Pharmacies”), and Yunnan Runcangsheng Technology Co., Ltd. (“Runcangsheng).” The Chinese Operatin… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| AIXN-DEBT | Debt stack $85,799 | 90% | Market cache reports total debt of $85,799. |